期刊文献+

孕激素在绝经后激素替代治疗中的应用 被引量:3

下载PDF
导出
作者 李淑芳
出处 《医学理论与实践》 2003年第11期1264-1265,共2页 The Journal of Medical Theory and Practice
  • 相关文献

参考文献10

  • 1Gambrell RD.Progestogens in estrogen-replacement .Clin Obstet Gynecol,1995,38:890 -901. 被引量:1
  • 2Ernster VL,Cummings SR.Progessterone and breast cancer.Obstet Gmecol, 1986,68:715 - 717. 被引量:1
  • 3Smilen SW, Nachtigall RD,et al.Incidence of breast cancer in a 22-year study of women receiving estrogen-progestin replacementtherapy.Obstet Gynecol,1992,80:827 - 830. 被引量:1
  • 4Bissonnette F,Lussier-Cacan S,fugere P,et al.Metabolic effect of two hormonal preparations in postmenopausal women.Maturitas,1997,27:275 --284. 被引量:1
  • 5De Cleyn K,Buytaert E,Coppens M.Carbohydrate metabolism during hormonalsubstitution therapy .Maturitas, 1989,11 : 235 - 242. 被引量:1
  • 6Gaspard UJ,Gottal JM,Van den Brule FA.Postmenopausal changes of lipid and glucose metabolism:a review of their main aspects.Maturitas,1995,21 : 171 - 178. 被引量:1
  • 7Ettinger B,Selby J,Citron JT,et al.Cyclic hormone replacement therapy using quaterly progestin .Obetet Gynecol,1994, 83: 693- 700. 被引量:1
  • 8Nand SL,Webster MA,Baber R,et al.Bleeding pattern and endometrial changes during continuous combined hormone replacement thearpy.Obstet Gynecol,1998,91:676 - 684. 被引量:1
  • 9Antoiniou G, Kalogirou D, Karakitsos P, et al.Transdermal with a levonorgestrel -releasing intrautering device for climacteric complaints versus estradiol-releasing vaginal ring with a vaginal progestrerone suppository:clinical and endometrial responses.Maturitas,1997,26:103- 111. 被引量:1
  • 10Unger JB, Rodney MG. Hysterectomy after endometrial ablation,Am J Obstet Gynecol, 1996,175:1432 - 1437. 被引量:1

同被引文献28

  • 1贺红,王树春,任长征,李继福,鹿庆华.男性冠心病患者血清孕酮水平与血脂的关系[J].中国动脉硬化杂志,1996,4(1):4-4. 被引量:4
  • 2贺红,杨发林,朱清,王梦欣,许德琴,苏继新.绝经后女性冠心病患者内源性女性激素分泌异常及其对一氧化氮合成的影响[J].中国动脉硬化杂志,2006,14(6):514-516. 被引量:5
  • 3Kuller LH. Hormone replacement therapy and risk of cardiovascular disease. Implications of the results of the Women's Health Initiative [ J ]. Arterioscler Thromb Vase Biol,2003,23 : 11-16. 被引量:1
  • 4Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progesterone in healthy postmenopausal women: principal results from the Women 's Health Initiative randomized controlled trial [ J ]. JAMA, 2002,288 : 321-333. 被引量:1
  • 5Stefanick ML. Estrogen, progestogens and cardiovascular risk[ J]. Reprod Med, 1999,44:221-226. 被引量:1
  • 6Moskowitz D. A comprehensive review of the safety and efficacy of bioidentical hormones for the management of menopause and related health risks [ J ]. Altern Med Rev, 2006,11:208-223. 被引量:1
  • 7Grodstein F, Stampfer M. The epidemiology of coronary heart disease and estrogen replacement in postmenopausal women [ J ]. Prog Cardiovasc Dis, 1995,38 : 199-210. 被引量:1
  • 8Liu JH, Muse KN. The effects of progestins on bone density and bone metabolism in postmenopausal women: a randomized controlled trial [ J ]. Am Obstet Gynecol, 2005,192 : 1316-1324. 被引量:1
  • 9Simoncini T, Genazzani AR. Non-genomic actions of sex steroid hormones [ J ]. Eur Endocrinol, 2003,148 : 281- 292. 被引量:1
  • 10朱榍光.《中国实用妇科与产科杂志》,关于《功能性失调子宫出血的临床生理和处理》.2001年4期. 被引量:1

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部